Kansas Bioscience Park Venture Accelerator

06/05/2015

Congratulations Kevin!

CFO of the Year 2015

05/12/2015

The Kansas City region has a robust mix of bioinformatics expertise, capabilities, and capacity within research organizations and the private sector. While these assets compare well to established bioinformatics hubs in the country, the region is challenged by the geographic distribution of expertis…

04/27/2015

Leawood-based Flyover Capital made its first investment in a locally based company, participating in a $3.7 million investment in Olathe-based Innara Health.

04/24/2015

Congratulations Kevin, KCBJ 2015 CFO of the year - nonprofits!

The Kansas City Business Journal recognizes the 2015 CFOs of the Year.

04/06/2015

Please welcome ECAS, our newest resident company. ECAS provides ASHRAE Level II Commercial Energy Auditing, Project Design and full EPC of EEM and research to implementation of biofuel and renewable fuel.

03/03/2015

Please join us in welcoming IntelligeneDX as a new Venture Accelerator tenant. IntelligeneDX is a genomic laboratory specialized in molecular analysis and development of molecular tests to diagnose, treat and prognosticate all types of cancer.

02/11/2015

On behalf of the Kansas City Animal Health Corridor Advisory Board, it is my pleasure to invite you to submit your nominations for the 2015 KC Animal Health Corridor Iron Paw award. The Iron Paw award is given to an individual from research, academia, industry or government, regardless of title, wh…

02/11/2015

KANSAS CITY, Mo. (Feb. 10, 2015) – Dairy Farmers of America (DFA), Kansas City’s largest private company with approximately $18 billion in revenue in 2014, has announced plans to build its new global headquarters in Kansas City, Kansas.

02/09/2015

Roughly four months after becoming a publicly traded company, Proteon Therapeutics Inc. opened Nasdaq’s trading day on Monday.

01/22/2015

Kansas City received further validation of its tech credentials Friday as the national conference Techweek plans to visit the area.

12/18/2014

The Kansas Bioscience Authority together with the KC Animal Health Corridor is pleased to join Advanced Animal Diagnostics (AAD) in the recent announcement that the company closed a $15 million Series C round of equity financing.

AAD presented in 2009 and 2011 at the KC Animal Health Investment Forum, a global event that has helped early and mid-stage animal health companies raise more than $150 million over the past six years.

AAD develops on-farm diagnostic technologies that change the way livestock producers manage animal health and costly diseases. The company expects to advance the development of additional livestock tests for dairy and beef markets, invest in production and manufacturing, and expand commercial efforts for new and existing customers with this financing. AAD plans to conduct limited product development research with the Kansas State Veterinary Diagnostics Lab in Manhattan, is working with a Lenexa manufacturer to make components of the Qscout Lab, and plans to establish a sales office in Western Kansas to support its current dairy product and future feedlot products.

The financing was co-led by the Kansas Bioscience Authority and Cultivian Sandbox, and included Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH), Middleland Capital, and existing investors Intersouth Partners, Novartis Venture Funds and private individuals. The investment will allow AAD to accelerate the commercialization of its current product offering, QScout® MLD (milk leukocyte differential) test, while also expanding the company’s product line.

“Bringing AAD to the KC Animal Health Corridor positions Kansas as a growing dairy state, as well as an innovative state that is bringing new technologies to the dairy market,” said Tony Simpson, managing director, Kansas Bioscience Authority.

“The KC Animal Health Investment Forum showcases the most innovative companies in animal health today, and AAD is the second presenting company to receive KBA funding to date.”

12/08/2014

DURHAM, NC — December 8, 2014 — Advanced Animal Diagnostics (AAD) announced today the close of a $15 million Series C round of equity financing. The financing was co-led by Cultivian Sandbox and Kansas Bioscience Authority and included Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH…